CSBR CIK: 771856

Champions Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
19.7
FY23:
19.5
FY24:
13.6
FY25:
22.4
FY26:
19.2
(positive)
Change from FY22 to FY26
millions USD
FY22:
15.7
FY23:
14.9
FY24:
12.5
FY25:
9.99
FY26:
7.77
Total assets
Change from FY22 to FY26
millions USD
FY22:
35.4
FY23:
34.3
FY24:
26.1
FY25:
32.3
FY26:
27.0

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
17.5
FY23:
21.7
FY24:
21.5
FY25:
23.9
FY26:
19.9
(negative)
Change from FY22 to FY26
millions USD
FY22:
8.80
FY23:
7.94
FY24:
6.49
FY25:
4.72
FY26:
3.00
(positive)
Change from FY22 to FY26
millions USD
FY22:
9.10
FY23:
4.64
FY24:
−1.90
FY25:
3.77
FY26:
3.94
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
35.4
FY23:
34.3
FY24:
26.1
FY25:
32.3
FY26:
26.9

All amounts in millions USD Data source:SEC EDGAR